V2 receptor antagonists in cystic kidney diseases: an exciting step towards a practical treatment

J Am Soc Nephrol. 2005 Apr;16(4):838-9. doi: 10.1681/ASN.2005020136. Epub 2005 Feb 23.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Animals
  • Antidiuretic Hormone Receptor Antagonists*
  • Benzazepines / therapeutic use
  • Humans
  • Kidney Diseases, Cystic / drug therapy*
  • Polycystic Kidney, Autosomal Dominant / drug therapy
  • Polycystic Kidney, Autosomal Recessive / drug therapy
  • Tolvaptan

Substances

  • Antidiuretic Hormone Receptor Antagonists
  • Benzazepines
  • Tolvaptan